FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort-Reference-Cited by-同舟云学术

FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort

Published:2016-09-30 Issue:46 Volume:7 Page:75729-75738
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Johnson Jeff¹,Choi Michael¹,Dadmanesh Farnaz²,Han Bingchen¹,Qu Ying¹,Yu-Rice Yi¹,Zhang Xiao³,Bagaria Sanjay⁴,Taylor Clive⁵,Giuliano Armando E.¹⁶,Amersi Farin¹⁶,Cui Xiaojiang¹⁶

Affiliation:

1. Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

2. Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

3. Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

4. Department of Surgery, Mayo Clinic, Jacksonville, FL 32224, USA

5. Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA

6. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotropy in FOXC1-attributable phenotypes involves altered ciliation and cilia-dependent signaling;Scientific Reports;2024-08-31

2. Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features;Breast Cancer Research;2024-08-28

3. NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges;Life Sciences;2024-07

4. Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial;JCO Precision Oncology;2024-02

5. Breast;Handbook of Practical Immunohistochemistry;2022